New study targets rare pancreatic cancer mutation with drug cocktails
Knowledge-focused
Recruiting now
This study follows 80 adults with advanced pancreatic cancer that has a specific genetic change called KRAS G12R. Researchers want to see how well treatments that combine a MEK inhibitor with other drugs work and how safe they are. Participants receive their usual care while data…
Sponsor: Mandana Kamgar, MD • Aim: Knowledge-focused
Last updated May 11, 2026 02:38 UTC